Country of study, study setting and study design, number of included studies (n, % total n)
| Number (% total*) of Studies | |
|---|---|
| Country of study | |
| Other Europe | 84 (28%) |
| UK | 81 (27%) |
| USA | 67 (22%) |
| Australia and New Zealand | 39 (13%) |
| Nordic Countries (Norway, Denmark, Finland, Sweden) | 48 (16%) |
| Canada | 28 (9%) |
| Asia | 13 (4%) |
| Middle East (Israel, India) | 8 (3%) |
| Study setting | |
| Acute | 237 (78%) |
| Postacute (any) | 24 (8%) |
| Across the continuum of care | 41 (14%) |
| Study design | |
| Retrospective cohort | 85 (28%) |
| Prospective cohort | 53 (18%) |
| Review (scoping, systematic, etc) | 50 (17%) |
| Randomised controlled trial | 34 (11%) |
| Clinical Audit | 31 (10%) |
| Experimental (eg, pre-post) | 19 (6%) |
| Population-based cohort | 9 (3%) |
| Descriptive | 7 (2%) |
| Cross-sectional | 6 (2%) |
| Focus groups/interviews/consensus meetings | 4 (1%) |
| Pilot study | 2 (1%) |
| Survey | 2 (1%) |
*The total percentage does not add up to 100% for country of study as some studies took place in multiple countries.